Fish & Richardson

Contact
Share
Info
One Marina Park Drive
Boston, MA 02110-1878, United States
Phone: +1 (617) 368-2115
Fax: (617) 542-8906
Areas Of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Class Action
  • Commercial Law & Contracts
  • Communications & Media Law
  • Constitutional Law
  • Finance & Banking
  • Intellectual Property
  • International Law & Trade
  • Litigation
  • Products Liability
  • Science, Computers, & Tech
  • Transportation
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Delaware
  • Georgia
  • Massachusetts
  • Minnesota
  • New York
  • Texas
Other Countries
  • China
Number of Attorneys
200+ Attorneys

ITC Round-Up: Q1 2025

The first quarter of 2025 saw the International Trade Commission issue the following public orders addressing a wide variety of issues ranging from evaluation of significance for domestic industry to staying remedial orders…more
 /  Administrative Law, Intellectual Property, International Law & Trade

Federal Circuit Clarifies Limits of Patent Eligibility for Machine Learning Claims

In a decision with implications for machine learning-related patent filings, the Federal Circuit in Recentive Analytics, Inc. v. Fox Corp., No. 2023-2437 (Fed. Cir. Apr. 18, 2025), affirmed the District of Delaware’s dismissal…more
 /  Communications & Media Law, Intellectual Property, Science, Computers, & Technology

More Is More: Ensure Your Mark Is Protectable Before You Enforce

The Federal Circuit’s recent decision in Heritage Alliance v. American Policy Roundtable, Case No. 24-1155 (Fed. Cir. Apr. 9, 2025), provides a salient reminder to brand owners seeking to build value in descriptive trademarks —…more
 /  Intellectual Property

[Webinar] Analyzing SEPs: Strategies for Licensing Negotiations - May 15th, 1:30 pm ET

Most standard setting organizations require their members to agree to license their standard essential patents (SEPs) on fair, reasonable, and non-discriminatory terms. But there is no bright-line rule for determining whether a…more
 /  Intellectual Property

Can Clinical Trials Negate Patentability for Pharma Inventions?

The answer to this inquiry is “yes” — but maybe “no.” Will confidentiality agreements shield any prior art concerns? Once again, maybe “yes” — but maybe “no.” Indeed, do clinical trials constitute an experimental use that does…more
 /  Commercial Law & Contracts, Intellectual Property, Science, Computers, & Technology

PTAB Issues FAQs on Interim Process for Workload Management

Last week, the Patent Trial and Appeal Board (PTAB) issued a list of FAQs related to the new bifurcated process for discretionary denial established in the March 26 memorandum issued by Acting Director Stewart. The FAQs follow…more
 /  Intellectual Property, Science, Computers, & Technology

Munich Appeals Court Reinforces Security-Centric FRAND Framework in SEP Dispute

Standard-essential patent (SEP) licensing remains a critical issue in Europe, where political bodies and national courts at times diverge in the interpretation of fair, reasonable, and non-discriminatory (FRAND) licensing…more
 /  Commercial Law & Contracts, Intellectual Property, Science, Computers, & Technology

Federal Circuit Finds Beer Trademark Application Nothing but "Chicken Scratch"

In yet another recent example of the need for care in establishing a full record when appealing the denial of a trademark application, on April 14, 2025, the U.S. Court of Appeals for the Federal Circuit upheld the denial of an…more
 /  Administrative Law, Intellectual Property

Trump’s Drug Price Executive Order: What Drugmakers Should Know

On April 15, 2025, President Trump issued an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order reaffirms and seeks to expand on policy initiatives introduced during the president’s…more
 /  Antitrust & Trade Regulation, Health, Science, Computers, & Technology

Key Insights From the UPC’s First SEP

In November 2024, the Local Division (LD) Mannheim of the Unified Patent Court (UPC) issued the UPC’s first-ever substantive decision on standard essential patents (SEPs) and fair, reasonable, and non-discriminatory (FRAND)…more
 /  Antitrust & Trade Regulation, Commercial Law & Contracts, Intellectual Property, International Law & Trade

EPRx 201: The Risks and Rewards of Ex Parte Reexamination

Ex parte reexamination (EPRx) comes with risks and rewards for both patent challengers and patent owners. Patent challengers enjoy a lower threshold for institution and avoid the estoppel risk of other post-grant proceedings but…more
 /  Administrative Law, Intellectual Property, Science, Computers, & Technology

TTAB Puts Pool Hall Behind the 8 Ball

On March 20, 2025, the U.S. Trademark Trial and Appeal Board (TTAB) granted an opposition filed by Jack’s Family Restaurants, LP, and denied an application filed by Jack’s Grill and Billiards, Inc., to register JACK’S DOWNTOWN…more
 /  Intellectual Property

Trademark Owners May Play Only Zone Defense at the TTAB

In a precedential decision invoking the “zone of natural expansion” doctrine, on March 19, 2025, the Federal Circuit upheld a decision by the U.S. Trademark Trial and Appeal Board (TTAB) cancelling in part registrations for…more
 /  Intellectual Property

What to Know About the PTAB’s Discretionary Denial Shakeups

The United States Patent and Trademark Office (USPTO) has recently made several significant changes that are reshaping discretionary denials at the Patent Trial and Appeal Board (PTAB)…more
 /  Administrative Law, Intellectual Property, Science, Computers, & Technology

EPRx 101: Getting to Know Ex Parte Reexamination

Ex parte reexamination (EPRx) is a powerful tool that allows any party — including the patent owner — to request that the United States Patent and Trademark Office (USPTO) reassess the validity of an issued patent based on prior…more
 /  Administrative Law, Intellectual Property, Science, Computers, & Technology
Showing 1-15 of 704 Results
/
View per page
Page: of 47
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide